Establishment Labs Holdings (ESTA) EBIT Margin (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly EBIT Margin of 10.87% in Q1 2026, down 78.79% quarter-over-quarter from 6.08% in Q4 2025, and up 3008.0% on a YoY basis from 0.35% in Q1 2025.
Establishment Labs Holdings (ESTA) EBIT Margin (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' EBIT Margin history runs 10 years deep, the most recent figure standing at 10.87% for Q1 2026.
- In Q1 2026, EBIT Margin rose 3008.0% year-over-year to 10.87%; the TTM figure through Mar 2026 stood at 12.45% (up 2168.0% YoY), while the FY2025 annual figure was 18.48%, up 1163.0% from the prior year.
- EBIT Margin was 10.87% for Q1 2026 at Establishment Labs Holdings, down from 6.08% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 6.08% in Q4 2025 to a low of 70.07% in Q4 2023.
- Historically, EBIT Margin has averaged 28.25% across 5 years, with a median of 27.5% in 2022.
- The sharpest annual moves came in 2023 and 2025: EBIT Margin slumped 4004 bps in 2023, then soared 3586 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 30.04% in 2022, then tumbled by 133 bps to 70.07% in 2023, then soared by 40 bps to 41.94% in 2024, then soared by 85 bps to 6.08% in 2025, then sank by 79 bps to 10.87% in 2026.
- The last three EBIT Margin figures came in at 10.87% (Q1 2026), 6.08% (Q4 2025), and 7.48% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | -10.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.87% |
| Dec 31, 2025 | -6.08% |
| Sep 30, 2025 | -7.48% |
| Jun 30, 2025 | -27.50% |
| Mar 31, 2025 | -40.96% |
| Dec 31, 2024 | -41.94% |
| Sep 30, 2024 | -32.66% |
| Jun 30, 2024 | -21.18% |
| Mar 31, 2024 | -23.77% |
| Dec 31, 2023 | -70.07% |
| Sep 30, 2023 | -54.64% |
| Jun 30, 2023 | -28.24% |
| Mar 31, 2023 | -17.54% |
| Dec 31, 2022 | -30.04% |
| Sep 30, 2022 | -27.50% |
| Jun 30, 2022 | -25.26% |
| Mar 31, 2022 | -14.50% |
| Dec 31, 2021 | -26.52% |
| Sep 30, 2021 | -31.14% |
| Jun 30, 2021 | -14.48% |